These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37431844)

  • 41. Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals.
    Cheng Y; Shen P; Tao Y; Zhang W; Xu B; Bi Y; Han Z; Zhou YH
    Front Public Health; 2022; 10():1025901. PubMed ID: 36568756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case-report and review of the literature.
    Oriot P; Hermans MP
    Acta Clin Belg; 2022 Feb; 77(1):113-117. PubMed ID: 32544373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 and Diabetes: will Novel Drugs for Diabetes Help in COVID-19?
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Dubey R; Prabhakar PK; Batiha GE
    Curr Mol Pharmacol; 2023; 16(4):494-506. PubMed ID: 36089790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury.
    Chen X; Guo H; Qiu L; Zhang C; Deng Q; Leng Q
    Front Immunol; 2020; 11():2056. PubMed ID: 32973814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.
    Penfornis A; Blicklé JF; Fiquet B; Quéré S; Dejager S
    Vasc Health Risk Manag; 2014; 10():341-52. PubMed ID: 24966684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased circulating microparticles contribute to severe infection and adverse outcomes of COVID-19 in patients with diabetes.
    Sun H; Du Y; Kumar R; Buchkovich N; He P
    Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1176-H1193. PubMed ID: 36269646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method.
    Petakh P; Kobyliak N; Kamyshnyi A
    Front Cell Infect Microbiol; 2023; 13():1142578. PubMed ID: 36844398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of SLC22A3 rs543159 and rs1317652 genetic variants on metformin therapeutic efficacy in newly diagnosed patients with type 2 diabetes mellitus: 25 weeks follow-up study.
    Taheri R; Kazerouni F; Mirfakhraei R; Kalbasi S; Shahrokhi SZ; Rahimipour A
    Gene; 2022 May; 823():146382. PubMed ID: 35240257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
    Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
    J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
    Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D
    Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes.
    Shao S; Yang Q; Pan R; Yu X; Chen Y
    Front Endocrinol (Lausanne); 2021; 12():731974. PubMed ID: 34690930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal function markers and metformin eligibility.
    Tavares Bello C; Castro Fonseca R; Sousa Santos F; Sequeira Duarte J; Azinheira J; Vasconcelos C
    Minerva Endocrinol; 2018 Sep; 43(3):246-252. PubMed ID: 28565889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus.
    Yang W; Sun X; Zhang J; Zhang K
    Diabetes Res Clin Pract; 2021 Aug; 178():108977. PubMed ID: 34302912
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of metformin in the treatment of estrogen-dependent endometrial carcinoma complicated with type 2 diabetes mellitus and analysis of its prognosis.
    Deng Y; Wang J; Li W; Xiong W; Wang X
    J BUON; 2020; 25(3):1534-1540. PubMed ID: 32862601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metformin - a new approach.
    Cwynar-Zając Ł
    Pediatr Endocrinol Diabetes Metab; 2021; 27(2):134-140. PubMed ID: 34514769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implications of SARS-CoV-2 infection on the clinical, hematological, and inflammatory parameters in COVID-19 patients: A retrospective cross-sectional study.
    Damiati LA; Bahlas S; Aljohaney A; Bawazir Y; Mustafa M; Denetiu I; Pushparaj PN
    J Infect Public Health; 2022 Feb; 15(2):214-221. PubMed ID: 35007842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients.
    Kumar A; Kumar P; Dungdung A; Kumar Gupta A; Anurag A; Kumar A
    Diabetes Metab Syndr; 2020; 14(6):1951-1954. PubMed ID: 33039937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes mellitus and COVID-19: review of a lethal interaction from the cellular and molecular level to the bedside.
    Ali Kazem T; Zeylabi F; Filayih Hassan A; Paridar P; Pezeshki SP; Pezeshki SMS
    Expert Rev Endocrinol Metab; 2022 Jan; 17(1):1-19. PubMed ID: 34781797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.